Blog

CRISPR Therapeutics to Present Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018 – GlobeNewswire (press release)


GlobeNewswire (press release)

CRISPR Therapeutics to Present Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
GlobeNewswire (press release)
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for
There Is Something To Be Excited About: Microsoft Corporation (MSFT), CRISPR Therapeutics AG (CRSP)Post Analyst


Technical note to watch on CRISPR Therapeutics AG (CRSP) –Wall Street Morning
Stock to Watch – CRISPR Therapeutics AG (NASDAQ: CRSP)Alpha Beta Stock

all 30 news articles »

2018-04-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.